Cubist Systematic Strategies, LLC Cytosorbents Corp Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.22 $9,375 - $17,152	-5,327 Reduced 29.83%	12,531 $27,000
Q1 2022 May 16, 2022	BUY	$2.88 - $4.23 $51,431 - $75,539	17,858 New	17,858 $57,000
Q3 2021 Nov 15, 2021	SELL	$7.0 - $9.71 $67,774 - $94,012	-9,682 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$7.55 - $9.42 $22,793 - $28,438	-3,019 Reduced 23.77%	9,682 $73,000
Q1 2021 May 17, 2021	SELL	$8.23 - $11.48 $205,001 - $285,955	-24,909 Reduced 66.23%	12,701 $110,000
Q4 2020 Feb 16, 2021	SELL	$7.65 - $8.98 $478,010 - $561,115	-62,485 Reduced 62.43%	37,610 $300,000
Q3 2020 Nov 16, 2020	BUY	$7.37 - $11.54 $266,477 - $417,251	36,157 Added 56.55%	100,095 $798,000
Q2 2020 Aug 14, 2020	BUY	$6.28 - $10.59 $401,530 - $677,103	63,938 New	63,938 $633,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.